Kilitch Drugs (India) Limited
KILITCH.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.59B
Close$
Share Statistics
| Market cap | $8.59 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $8.91 |
| Beta | 0.36 |
| Outstanding Shares | 34,961,564 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 27.38 |
|---|---|
| PEG | -733.77 |
| Price to Sales | 3.44 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Kilitch Drugs (India) Limited
236 employees
CEO: Mukund Prataprai Mehta Kilitch Drugs (India) Limited operates as a pharmaceutical enterprise primarily within India, with an active presence in international markets through product exports. Established in Mumbai in 1978, the company manufactures a diverse por...